Palmer, Andrew J <br/><br/>
A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Apr 2008 
 - 1216-23 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfn082  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Distribution<br/>Aged<br/>Aged, 80 and over<br/>Angiotensin II Type 1 Receptor Blockers--economics<br/>Cost-Benefit Analysis<br/>Diabetes Mellitus, Type 2--complications<br/>Disease-Free Survival<br/>Female<br/>Health Care Costs<br/>Humans<br/>Hypertension--complications<br/>Hypoglycemic Agents--therapeutic use<br/>Incidence<br/>Kidney Failure, Chronic--complications<br/>Life Expectancy--trends<br/>Male<br/>Mass Screening--economics<br/>Middle Aged<br/>Models, Economic<br/>Morbidity--trends<br/>Prognosis<br/>Quality of Life<br/>Renal Insufficiency--drug therapy<br/>Survival Rate--trends<br/>United States--epidemiology